Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
  • About Us
    • Editorial Profile
    • Editorial Calendar
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
 
 
 
 
  • Deep Genomics Raises $13 Million To Develop Genetic Medicines

    Bio-IT World Brief | Deep Genomics received a USD $13 million equity investment led by Khosla Ventures. They are accompanied by early stage investment firm True Ventures. In the next three years, Deep Genomics will use its platform to unlock new classes of anti-sense oligonucleotide therapies that were previously inaccessible, and advance them for clinical evaluation.

    Sep 25, 2017
  • Congenica, PerkinElmer, Illumina, And More: News From September 2017

    Bio-IT World | September featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Congenica, PerkinElmer, Illumina, and more.

    Sep 25, 2017
  • Jackson Lab Files Federal Complaint, Accusing Chinese University Of Selling Its Mice

    Hartford Courant | The Jackson Laboratory is suing to stop Nanjing University, whom it accuses of selling offspring of the genomics center’s mice used for research.

    Sep 22, 2017
  • Even At $500K, Gene Therapy Could Be A Bargain For Some Diseases

    MIT Technology Review | A one-time gene therapy that costs half a million dollars sounds crazy until you add up what it costs to treat some diseases over a lifetime.

    Sep 21, 2017
  • CRISPR Used To Peer Into Human Embryo's First Days

    Nature News & Comment | Gene-edited embryos enable researchers to unpick role of a crucial gene, with more studies likely to follow.

    Sep 20, 2017
  • Edico Genome’s DRAGEN Now Available On Illumina’s BaseSpace Sequence Hub

    Bio-IT World Brief | Edico Genome today announced the availability of its DRAGEN Bio-IT Platform on Illumina’s BaseSpace Sequence Hub, enabling users to now run DRAGEN instances to enhance the accuracy and speed of their secondary analysis of next-generation sequencing data.

    Sep 19, 2017
  • Amazon Announces Per-Second Billing For EC2 Instances And EBS Volumes

    AWS Blog | Amazon has announced that, effective October 2, usage of Linux instances that are launched in On-Demand, Reserved, and Spot form will be billed in one-second increments. Similarly, provisioned storage for EBS volumes will be billed in one-second increments. Per-second billing also applies to Amazon EMR and AWS Batch.

    Sep 18, 2017
  • Earlham Institute Presents Sequence Alignment Using Optalysys’ Optical Correlator Computing System

    Bio-IT World | 2017 Best Practices Awards | The Earlham Institute are working with Optalysys to apply Optalysys’ optical computing system to life science applications. The first release of the computing system is scheduled for early 2018, which both organizations say will be capable of performing a number of different DNA-based local sequence alignment applications.

    Sep 18, 2017
  • «
  • 151
  • 152
  • 153
  • 154
  • 155 (current)
  • 156
  • 157
  • 158
  • 159
  • 160
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: [email protected]

Twitter Icon LinkedIn Icon Facebook Icon

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy